SGS is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland with a new 200m2 lab. The lab will be equipped with a number of new instruments to help meet the growing need for biopharmaceutical studies during the early and late phase of characterization, as required by the ICH guidelines.   Scheduled to open in 3Q18, the new lab will offer services for high order structure analysis of biologics, including circular dichroism (CD), Fourier-transform infrared spectroscopy (FT...